Concepedia

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

Milagritos D. Tapia, Samba O. Sow, B Ndiaye, Khardiata Diallo Mbaye, Aliou Thiongane, Cheikh Ndour, Souleymane Mboup, Julie A. Ake, Babajide Keshinro, Akindiran Akintunde,

The Lancet Infectious Diseases · 2020 · 76 citations · 35 references

DOIFull text

Open access

Concepts

References

35

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

Ana María Henao-Restrepo, Anton Camacho, Ira M. Longini et al. · The Lancet · 2016 · 1.1K citations · Full text

, , +17

Development of a preventive vaccine for Ebola virus infection in primates

Nancy J. Sullivan, Anthony Sanchez, Pierre E. Rollin et al. · Nature · 2000 · 661 citations

, , +14

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

Nancy J. Sullivan, Thomas W. Geisbert, Joan B. Geisbert et al. · Nature · 2003 · 463 citations · Full text

, , +14

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Sélidji Todagbé Agnandji, Angela Huttner, Madeleine E. Zinser et al. · New England Journal of Medicine · 2015 · 413 citations · Full text

, , +17

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

Katie Ewer, Tommy Rampling, Navin Venkatraman et al. · New England Journal of Medicine · 2015 · 356 citations · Full text

, , +14